Short-course hypofractionated proton beam therapy, incorporating 18 F-DOPA PET and contrast-enhanced...
Short-course hypofractionated proton beam therapy, incorporating 18 F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
About this item
Full title
Author / Creator
Vora, Sujay , Pafundi, Deanna , Voss, Molly , Buras, Matthew , Ashman, Jonathan , Bendok, Bernard , Breen, William , Hu, Leland , Kizilbash, Sani , Laack, Nadia , Liu, Wei , Mahajan, Anita , Mrugala, Maciej , Porter, Alyx , Ruff, Michael , Sio, Terence , Uhm, Joon , Yang, Ming , Brinkmann, Debra and Brown, Paul
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Older patients (aged ≥65 years) with glioblastoma have a worse prognosis than younger patients and a median overall survival of 6-9 months. 3,4-Dihydroxy-6-[
F]fluoro-L-phenylalanine (
F-DOPA) PET sensitively and specifically identifies metabolically active glioblastoma for preferential targeting. Proton beam therapy potentially improves qual...
Alternative Titles
Full title
Short-course hypofractionated proton beam therapy, incorporating 18 F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3135051052
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3135051052
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(24)00585-0
